3.11
price up icon1.63%   0.05
after-market Handel nachbörslich: 2.97 -0.14 -4.50%
loading
Schlusskurs vom Vortag:
$3.06
Offen:
$3.02
24-Stunden-Volumen:
20,263
Relative Volume:
0.01
Marktkapitalisierung:
$11.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$1.52M
KGV:
-0.492
EPS:
-6.3213
Netto-Cashflow:
$-1.14M
1W Leistung:
+1.63%
1M Leistung:
-11.40%
6M Leistung:
-37.02%
1J Leistung:
-89.85%
1-Tages-Spanne:
Value
$2.93
$3.2099
1-Wochen-Bereich:
Value
$2.93
$3.275
52-Wochen-Spanne:
Value
$0.6254
$74.94

Psyence Biomedical Ltd Stock (PBM) Company Profile

Name
Firmenname
Psyence Biomedical Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
12
Name
Twitter
Name
Nächster Verdiensttermin
2026-06-24
Name
Neueste SEC-Einreichungen
Name
PBM's Discussions on Twitter

Compare PBM vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
PBM icon
PBM
Psyence Biomedical Ltd
3.11 11.67M 0 1.52M -1.14M -6.3213
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
522.25 134.41B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
676.23 68.13B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
919.94 57.01B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
321.59 41.79B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
190.46 40.39B 742.00K -1.37B -1.07B -7.0731

Psyence Biomedical Ltd Aktie (PBM) Neueste Nachrichten

pulisher
Jul 03, 2026

PBMPsyence Biomedical Ltd Earnings - Finviz

Jul 03, 2026
pulisher
Jun 30, 2026

Tranche Update on Psyence Biomedical Ltd.'s Equity Buyback Plan announced on January 12, 2026. - marketscreener.com

Jun 30, 2026
pulisher
Jun 28, 2026

PBM Stock On Track For Best Session On Report Of Upcoming Trump Executive Order On Psychedelic Ibogaine - Stocktwits

Jun 28, 2026
pulisher
Jun 25, 2026

Psyence Biomedical Ltd (PBM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 25, 2026
pulisher
Jun 24, 2026

$Psyence Biomedical (PBM.US)$ - Moomoo

Jun 24, 2026
pulisher
Jun 22, 2026

Psyence Biomedical (Nasdaq: PBM) outlines losses, cash runway and trial risks in 20-F - Stock Titan

Jun 22, 2026
pulisher
Jun 22, 2026

Psyence Biomedical Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com

Jun 22, 2026
pulisher
Jun 21, 2026

Nasdaq, S&P 500 Futures Fall, Oil Risk Back In Focus After Trump’s Iran Escalation: Why PBM, FRMI, ASTS, BATL Are Keeping Traders Engaged Today - Stocktwits

Jun 21, 2026
pulisher
Jun 18, 2026

Psyence Biomedical Ltd (PBM) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

PBMWW | Psyence Biomedical Ltd. Warrant Insider Trading - Quiver Quantitative

Jun 18, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBM) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBMWW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBMWW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBMWW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBMWW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBMWW) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBMWW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBMWW) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBMWW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Psyence Biomedical Ltd (PBMWW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 12, 2026

PBM News | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill

Jun 12, 2026
pulisher
Jun 11, 2026

PBMWW Warrants Slide 9.25% as Psyence Biomedical Faces Continued Selling PressureGamma Exposure - newsline.com

Jun 11, 2026
pulisher
Jun 10, 2026

Jeffrey Weiner holds 59,750 shares in PSYENCE BIOMEDICAL LTD. (PBM) - Stock Titan

Jun 10, 2026
pulisher
Jun 09, 2026

Psyence Biomedical Company Profile & Introduction - Moomoo

Jun 09, 2026
pulisher
Jun 05, 2026

Psyence Biomedical Corrects Technical Error in 2023 Equity Incentive Plan - TipRanks

Jun 05, 2026
pulisher
Jun 05, 2026

Psyence Biomedical (PBM) corrects error in 2023 equity incentive plan - Stock Titan

Jun 05, 2026
pulisher
Jun 04, 2026

Psyence Biomedical draws attention premarket after filing on 30% stake - Bez Kabli

Jun 04, 2026
pulisher
Jun 03, 2026

Psyence Biomedical (PBM) Surges Over 7%: Bullish Momentum Builds Near ResistanceEnding Diagonal - newsline.com

Jun 03, 2026
pulisher
Jun 03, 2026

Psyence Labs Discloses Investment in PSYENCE BIOMEDICAL LTD. with 30.05% Stake - TradingView

Jun 03, 2026
pulisher
Jun 03, 2026

Psyence Labs gains 30.05% ownership of Psyence Biomedical (PBM) - Stock Titan

Jun 03, 2026
pulisher
May 27, 2026

Psyence Biomedical Ltd. Warrant (PBMWW) Slides 8.94% as Stock Hovers at $0.03Market Cap Weight - The Legal Advocate

May 27, 2026
pulisher
May 26, 2026

Psyence Biomedical (PBM) Rallies 5.85% as Shares Test Key Resistance Near $4.56Value Area High - The Legal Advocate

May 26, 2026
pulisher
May 25, 2026

Psyence Biomedical Ltd. (PBM) Edges Higher Amid Sector Rotation and Key Technical LevelsUpthrust Pattern - The Legal Advocate

May 25, 2026
pulisher
May 25, 2026

Psyence Biomedical Warrants (PBMWW) Edge Higher; Support and Resistance Converge at $0.03Momentum Breakout Ideas - The Legal Advocate

May 25, 2026
pulisher
May 19, 2026

$Psyence Biomedical (PBM.US)$ picked me up lets goooo - Moomoo

May 19, 2026
pulisher
May 18, 2026

Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing - marketscreener.com

May 18, 2026
pulisher
May 15, 2026

Psyence BioMed Announces U.S. Strategic Engagement - GlobeNewswire

May 15, 2026
pulisher
May 15, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 15, 2026
pulisher
May 13, 2026

PBM Stock Chart | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill

May 13, 2026
pulisher
May 11, 2026

TradingKey - TradingKey

May 11, 2026

Finanzdaten der Psyence Biomedical Ltd-Aktie (PBM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$112.84
price up icon 1.17%
$57.80
price up icon 1.55%
$36.31
price up icon 2.60%
$79.77
price down icon 2.48%
ONC ONC
$308.96
price down icon 0.16%
$190.46
price up icon 0.25%
Kapitalisierung:     |  Volumen (24h):